Evidence map›Paper›PMID 10655223›Full record

ArticleGenetics2000

A genetic screen for novel components of the Ras/Mitogen-activated protein kinase signaling pathway that interact with the yan gene of Drosophila identifies split ends, a new RNA recognition motif-containing protein.

I Rebay, F Chen, F Hsiao, P A Kolodziej, B H Kuang, T Laverty, C Suh, M Voas, A Williams, G M Rubin

Open access · bronzeAbstract read
In one paragraph

Article in Genetics, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 76 papers.

0numbers the graph read from it
0cells of the map it votes in
76citing papers in PubMed
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

76 citing papers in PubMed, 132 citations in OpenAlex.

  1. TheeLife · 2026
    Article
  2. Article
  3. Exploring the role of mFrontiers in oncology · 2024
    Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Transcriptomes Divergence ofFrontiers in genetics · 2018
    Article
  19. Article
  20. Article

16 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

I RebayWhitehead Institute for Biomedical Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02142, USA. rebay@wi.mit.edu
F Chen
F Hsiao
P A Kolodziej
B H Kuang
T Laverty
C Suh
M Voas
A Williams
G M Rubin
Howard Hughes Medical Institute · USWhitehead Institute for Biomedical Research · USUniversity of California, Berkeley · USMassachusetts Institute of Technology · USVanderbilt University Medical Center · US

Funding

CONTROL OF GENE EXPRESSION IN ANIMAL CELLSR01GM033135 · NIGMS · UNIVERSITY OF CALIFORNIA BERKELEY · PI RUBIN, GERALD M. · 1985 to 1988
–
CONTROL OF GENE EXPRESSION IN CELLSR37GM033135 · NIGMS · UNIVERSITY OF CALIFORNIA BERKELEY · PI RUBIN, GERALD M. · 1989 to 1998
–
NIGMS NIH HHS GM-33135
6 · The paper itself

Abstract

The receptor tyrosine kinase (RTK) signaling pathway is used reiteratively during the development of all multicellular organisms. While the core RTK/Ras/MAPK signaling cassette has been studied extensively, little is known about the nature of the downstream targets of the pathway or how these effectors regulate the specificity of cellular responses. Drosophila yan is one of a few downstream components identified to date, functioning as an antagonist of the RTK/Ras/MAPK pathway. Previously, we have shown that ectopic expression of a constitutively active protein (yan(ACT)) inhibits the differentiation of multiple cell types. In an effort to identify new genes functioning downstream in the Ras/MAPK/yan pathway, we have performed a genetic screen to isolate dominant modifiers of the rough eye phenotype associated with eye-specific expression of yan(ACT). Approximately 190,000 mutagenized flies were screened, and 260 enhancers and 90 suppressors were obtained. Among the previously known genes we recovered are four RTK pathway components, rolled (MAPK), son-of-sevenless, Star, and pointed, and two genes, eyes absent and string, that have not been implicated previously in RTK signaling events. We also isolated mutations in five previously uncharacterized genes, one of which, split ends, we have characterized molecularly and have shown to encode a member of the RRM family of RNA-binding proteins.

Indexed as

Drosophila ProteinsMAP Kinase Signaling SystemAmino Acid SequenceAnimalsBase SequenceDNADrosophilaEyeEye ProteinsHomeodomain ProteinsMaleMicroscopy, Electron, ScanningMolecular Sequence DataNuclear ProteinsRepressor ProteinsRNA-Binding ProteinsAOP protein, DrosophilaDNADrosophila ProteinsEye ProteinsHomeodomain ProteinsNuclear ProteinsRepressor ProteinsRNA-Binding ProteinsSpen protein, Drosophila

Identifiers

PMID10655223
PMCPMC1460949
OpenAlexW2127647363

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.